STRS Ohio’s MapLight Therapeutics MPLT Stock Holding History

STRS Ohio’s Portfolio MPLT Stock Details MPLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,000	Closed	-$61K	–	2373
2026 Q1	$61K	Hold	3,000	–	–	﹤0.01%	1895
2025 Q4	$52.7K	Buy	+3,000	New	+$50.3K	﹤0.01%	1964

Other funds holding MPLT

NHAS

Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return

FIS

FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

STRS Ohio's MPLT Position: Q2 2026 in Review

STRS Ohio sold out of MapLight Therapeutics (MPLT) in Q2 2026, closing a stake of 3,000 shares — an estimated $61K sold.

STRS Ohio first reported a position in MPLT in Q4 2025 and held it in 2 quarters. The position peaked at $61K in Q1 2026. 100 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

STRS Ohio reported no remaining MapLight Therapeutics position as of Q2 2026 after selling out during the quarter.
STRS Ohio sold 3,000 MapLight Therapeutics shares in Q2 2026, an estimated $61K.
STRS Ohio first reported a position in MapLight Therapeutics in Q4 2025 and held it in 2 quarters.
STRS Ohio's MapLight Therapeutics position peaked at $61K in Q1 2026.
100 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.